Ziconotide
A powerful pain-relief peptide derived from cone snail venom. Reserved for severe chronic pain when other treatments haven't worked.
This peptide is an FDA-approved drug product that can be legally prescribed by licensed clinicians.
The basics
- Generic Name
- ziconotide (peptide analgesic)
- Brand Names
- Prialt
- Regulatory Status
- Prescribed by Doctors
- Therapeutic Areas
- Pain Management
- Prescribing Specialties
- Pain medicine, Anesthesiology
What it does
Ziconotide is an FDA-approved medication that your doctor can prescribe. Synthetic omega-conotoxin peptide derived from cone snail venom that selectively blocks N-type voltage-gated calcium channels in the spinal cord dorsal horn, interrupting pain signal transmission.
How it's taken
Continuous intrathecal infusion via implanted pump
How people access it
Administered via a surgically implanted intrathecal pump in a clinical setting. Reserved for severe chronic pain.
What doctors prescribe it for
- Severe chronic pain in patients for whom intrathecal therapy is warranted and who are intolerant of or refractory to other treatments
Clinicians may prescribe FDA-approved drugs for off-label uses based on their clinical judgment. Off-label indications have not undergone the same FDA review process as the labeled uses listed above.
How to know it's legit
You can independently verify the FDA-approval status of Ziconotide through these free, publicly available databases:
- DailyMed (dailymed.nlm.nih.gov) — Search for Prialt to find the current FDA-approved labeling, including indications, dosing, warnings, and contraindications.
- Drugs@FDA (accessdata.fda.gov/scripts/cder/daf/) — Search to find the original approval letter, review documents, and approval history.
- FDA Orange Book (orangebook.fda.gov) — Search for therapeutic equivalence evaluations and patent/exclusivity information.
Common Questions
Yes. Ziconotide (Prialt) is an FDA-approved drug product. It has undergone rigorous review of safety, efficacy, and manufacturing quality by the FDA. It can be legally prescribed by licensed clinicians for its approved indications.
Ziconotide is FDA-approved for: Severe chronic pain in patients for whom intrathecal therapy is warranted and who are intolerant of or refractory to other treatments. Off-label use may be considered by clinicians on a case-by-case basis, but only the labeled indications have been reviewed and approved by the FDA.
You can verify the approval status of Ziconotide through several official FDA resources: DailyMed (dailymed.nlm.nih.gov) for current labeling, Drugs@FDA (accessdata.fda.gov/scripts/cder/daf/) for approval history, and the FDA Orange Book for therapeutic equivalence information. These are free, publicly available databases.
Want to learn more?
Explore how Ziconotide compares to other options, or dive deeper into how FDA approval works.
Explore All Peptides